Compare Novartis AG (NVS) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Oatly Group AB - ADR — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Oatly Group AB - ADR trades at $9.85 (market cap $308.50M). The key difference: Novartis AG is far larger — about 940.8× Oatly Group AB - ADR's market cap, and Novartis AG pays a 3.17% dividend while Oatly Group AB - ADR pays none. Which is the better fit depends on your goals.
| NVS | OTLY | |
|---|---|---|
Market Cap | $290.25B | $308.50M |
Sector | Health | Consumer Staples |
52-Week High | $168.62 | $18.54 |
52-Week Low | $113.50 | $8.03 |
Enterprise Value | $330.27B | $806.12M |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
